Rizatriptan Benzoate
Product Images NDC 63629-7433

5 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rizatriptan Benzoate (NDC 63629-7433). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl636297433)

Label Image (Lbl636297433)
Label for Rizatriptan Benzoate 10mg tablets in blister packaging from Bryant Ranch Prepack. The label compares this product to Maxalt 10mg Tablet (Blister) by InvaGen Pharmaceuticals Inc. It shows storage instructions, lot number, RX only designation, and includes a barcode and NDC 63629-7433.*
FDA Label Image

Rizatriptan 01

Rizatriptan 01
Chemical structure of Rizatriptan Benzoate showing the molecular arrangement of its constituent atoms including an indole ring system and a benzoate moiety.*
FDA Label Image

Rizatriptan 02

Rizatriptan 02
A line graph showing the estimated probability of response over time in hours post-dose for placebo, Rizatriptan Benzoate tablets 5 mg, and Rizatriptan Benzoate tablets 10 mg. The graph compares their response rates from 0 to 2 hours post-dose, with Rizatriptan Benzoate 10 mg showing the highest response probability.*
FDA Label Image

Rizatriptan 03

Rizatriptan 03
A line graph showing the estimated probability of medication or rescue over 24 hours post-dose for placebo, Rizatriptan Benzoate Tablets 5 mg, and 10 mg. The x-axis represents hours post-dose, and the y-axis shows the estimated probability percentage from 0% to 100%. Three curves illustrate the probability trends for each treatment group over time.*
FDA Label Image

Rizatriptan 04

Rizatriptan 04
A line graph comparing the percent effect over 2 hours post stage 2 dose between Rizatriptan Benzoate orally disintegrating tablets and placebo. The x-axis shows hours post dose, and the y-axis shows percent effect with 95% confidence intervals indicated by error bars.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.